Vtama and Zoryve Will Be the Latest Topicals for Psoriasis
October 2022
You may see Vtama (tapinarof) and Zoryve (roflumilast), new Rx creams for psoriasis, pop up on home med lists.
Both will be touted as steroid-free options that are safe for long-term use, even on thin-skinned areas (face, groin, etc).
But there’s no proof Vtama 1% or Zoryve 0.3% is more effective than other topicals for psoriasis (steroids, calcipotriene, etc)...or that one is more effective than another.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote